MAPT and Alzheimer disease: In AD, this integration has been particularly insightful, as spatial transcriptomics combined with amyloid and tau imaging has identified regions of heightened transcriptional dysregulation, advancing our understanding of how localized molecular changes contribute to disease progression [78,79].